nodes	percent_of_prediction	percent_of_DWPC	metapath
Metipranolol—Uveitis—Azathioprine—multiple sclerosis	0.051	0.051	CcSEcCtD
Metipranolol—Blepharitis—Cladribine—multiple sclerosis	0.0356	0.0356	CcSEcCtD
Metipranolol—Bronchitis—Fingolimod—multiple sclerosis	0.0233	0.0233	CcSEcCtD
Metipranolol—Bradycardia—Fingolimod—multiple sclerosis	0.0198	0.0198	CcSEcCtD
Metipranolol—Atrial fibrillation—Cladribine—multiple sclerosis	0.0168	0.0168	CcSEcCtD
Metipranolol—Arthritis—Cladribine—multiple sclerosis	0.0164	0.0164	CcSEcCtD
Metipranolol—Blepharitis—Betamethasone—multiple sclerosis	0.016	0.016	CcSEcCtD
Metipranolol—Blepharitis—Dexamethasone—multiple sclerosis	0.016	0.016	CcSEcCtD
Metipranolol—Vision blurred—Fingolimod—multiple sclerosis	0.0159	0.0159	CcSEcCtD
Metipranolol—Palpitations—Fingolimod—multiple sclerosis	0.0149	0.0149	CcSEcCtD
Metipranolol—Cough—Fingolimod—multiple sclerosis	0.0147	0.0147	CcSEcCtD
Metipranolol—Hypertension—Fingolimod—multiple sclerosis	0.0146	0.0146	CcSEcCtD
Metipranolol—Dyspnoea—Fingolimod—multiple sclerosis	0.0123	0.0123	CcSEcCtD
Metipranolol—Conjunctivitis—Cladribine—multiple sclerosis	0.0119	0.0119	CcSEcCtD
Metipranolol—Epistaxis—Cladribine—multiple sclerosis	0.0116	0.0116	CcSEcCtD
Metipranolol—Asthenia—Fingolimod—multiple sclerosis	0.00989	0.00989	CcSEcCtD
Metipranolol—Dizziness—Fingolimod—multiple sclerosis	0.00912	0.00912	CcSEcCtD
Metipranolol—Headache—Fingolimod—multiple sclerosis	0.00864	0.00864	CcSEcCtD
Metipranolol—Cough—Cladribine—multiple sclerosis	0.00836	0.00836	CcSEcCtD
Metipranolol—Myalgia—Cladribine—multiple sclerosis	0.00815	0.00815	CcSEcCtD
Metipranolol—Anxiety—Cladribine—multiple sclerosis	0.00813	0.00813	CcSEcCtD
Metipranolol—Discomfort—Cladribine—multiple sclerosis	0.00806	0.00806	CcSEcCtD
Metipranolol—Acute coronary syndrome—Mitoxantrone—multiple sclerosis	0.00794	0.00794	CcSEcCtD
Metipranolol—Myocardial infarction—Mitoxantrone—multiple sclerosis	0.0079	0.0079	CcSEcCtD
Metipranolol—Conjunctivitis—Mitoxantrone—multiple sclerosis	0.00783	0.00783	CcSEcCtD
Metipranolol—Oedema—Cladribine—multiple sclerosis	0.00782	0.00782	CcSEcCtD
Metipranolol—Bradycardia—Mitoxantrone—multiple sclerosis	0.00736	0.00736	CcSEcCtD
Metipranolol—Rhinitis—Mitoxantrone—multiple sclerosis	0.00725	0.00725	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.00712	0.00712	CcSEcCtD
Metipranolol—Dyspnoea—Cladribine—multiple sclerosis	0.00697	0.00697	CcSEcCtD
Metipranolol—Somnolence—Cladribine—multiple sclerosis	0.00695	0.00695	CcSEcCtD
Metipranolol—Myalgia—Azathioprine—multiple sclerosis	0.00663	0.00663	CcSEcCtD
Metipranolol—Bronchitis—Triamcinolone—multiple sclerosis	0.00656	0.00656	CcSEcCtD
Metipranolol—Discomfort—Azathioprine—multiple sclerosis	0.00655	0.00655	CcSEcCtD
Metipranolol—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.00652	0.00652	CcSEcCtD
Metipranolol—Myocardial infarction—Prednisolone—multiple sclerosis	0.00648	0.00648	CcSEcCtD
Metipranolol—Conjunctivitis—Prednisolone—multiple sclerosis	0.00643	0.00643	CcSEcCtD
Metipranolol—Bradycardia—Prednisolone—multiple sclerosis	0.00604	0.00604	CcSEcCtD
Metipranolol—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.00599	0.00599	CcSEcCtD
Metipranolol—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.00598	0.00598	CcSEcCtD
Metipranolol—Myocardial infarction—Triamcinolone—multiple sclerosis	0.00596	0.00596	CcSEcCtD
Metipranolol—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.00595	0.00595	CcSEcCtD
Metipranolol—Vision blurred—Mitoxantrone—multiple sclerosis	0.00593	0.00593	CcSEcCtD
Metipranolol—Conjunctivitis—Triamcinolone—multiple sclerosis	0.00591	0.00591	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.00579	0.00579	CcSEcCtD
Metipranolol—Hypersensitivity—Cladribine—multiple sclerosis	0.00576	0.00576	CcSEcCtD
Metipranolol—Epistaxis—Triamcinolone—multiple sclerosis	0.00573	0.00573	CcSEcCtD
Metipranolol—Visual impairment—Prednisolone—multiple sclerosis	0.00572	0.00572	CcSEcCtD
Metipranolol—Asthenia—Cladribine—multiple sclerosis	0.00561	0.00561	CcSEcCtD
Metipranolol—Bradycardia—Triamcinolone—multiple sclerosis	0.00556	0.00556	CcSEcCtD
Metipranolol—Bradycardia—Methylprednisolone—multiple sclerosis	0.00554	0.00554	CcSEcCtD
Metipranolol—Cough—Mitoxantrone—multiple sclerosis	0.00549	0.00549	CcSEcCtD
Metipranolol—Rhinitis—Triamcinolone—multiple sclerosis	0.00547	0.00547	CcSEcCtD
Metipranolol—Rhinitis—Methylprednisolone—multiple sclerosis	0.00546	0.00546	CcSEcCtD
Metipranolol—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.00544	0.00544	CcSEcCtD
Metipranolol—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.00544	0.00544	CcSEcCtD
Metipranolol—Hypertension—Mitoxantrone—multiple sclerosis	0.00544	0.00544	CcSEcCtD
Metipranolol—Myocardial infarction—Dexamethasone—multiple sclerosis	0.00541	0.00541	CcSEcCtD
Metipranolol—Myocardial infarction—Betamethasone—multiple sclerosis	0.00541	0.00541	CcSEcCtD
Metipranolol—Conjunctivitis—Betamethasone—multiple sclerosis	0.00536	0.00536	CcSEcCtD
Metipranolol—Conjunctivitis—Dexamethasone—multiple sclerosis	0.00536	0.00536	CcSEcCtD
Metipranolol—Myalgia—Mitoxantrone—multiple sclerosis	0.00536	0.00536	CcSEcCtD
Metipranolol—Anxiety—Mitoxantrone—multiple sclerosis	0.00534	0.00534	CcSEcCtD
Metipranolol—Discomfort—Mitoxantrone—multiple sclerosis	0.0053	0.0053	CcSEcCtD
Metipranolol—Visual impairment—Methylprednisolone—multiple sclerosis	0.00525	0.00525	CcSEcCtD
Metipranolol—Dizziness—Cladribine—multiple sclerosis	0.00517	0.00517	CcSEcCtD
Metipranolol—Oedema—Mitoxantrone—multiple sclerosis	0.00514	0.00514	CcSEcCtD
Metipranolol—Bradycardia—Dexamethasone—multiple sclerosis	0.00504	0.00504	CcSEcCtD
Metipranolol—Bradycardia—Betamethasone—multiple sclerosis	0.00504	0.00504	CcSEcCtD
Metipranolol—Rash—Cladribine—multiple sclerosis	0.00493	0.00493	CcSEcCtD
Metipranolol—Dermatitis—Cladribine—multiple sclerosis	0.00492	0.00492	CcSEcCtD
Metipranolol—Headache—Cladribine—multiple sclerosis	0.0049	0.0049	CcSEcCtD
Metipranolol—Vision blurred—Prednisolone—multiple sclerosis	0.00487	0.00487	CcSEcCtD
Metipranolol—Visual impairment—Dexamethasone—multiple sclerosis	0.00477	0.00477	CcSEcCtD
Metipranolol—Visual impairment—Betamethasone—multiple sclerosis	0.00477	0.00477	CcSEcCtD
Metipranolol—Acute coronary syndrome—Prednisone—multiple sclerosis	0.00473	0.00473	CcSEcCtD
Metipranolol—Myocardial infarction—Prednisone—multiple sclerosis	0.00471	0.00471	CcSEcCtD
Metipranolol—Hypersensitivity—Azathioprine—multiple sclerosis	0.00468	0.00468	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.00468	0.00468	CcSEcCtD
Metipranolol—Nausea—Cladribine—multiple sclerosis	0.00464	0.00464	CcSEcCtD
Metipranolol—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00458	0.00458	CcSEcCtD
Metipranolol—Somnolence—Mitoxantrone—multiple sclerosis	0.00457	0.00457	CcSEcCtD
Metipranolol—Hypertension—Prednisolone—multiple sclerosis	0.00446	0.00446	CcSEcCtD
Metipranolol—Bradycardia—Prednisone—multiple sclerosis	0.00439	0.00439	CcSEcCtD
Metipranolol—Discomfort—Prednisolone—multiple sclerosis	0.00434	0.00434	CcSEcCtD
Metipranolol—Oedema—Prednisolone—multiple sclerosis	0.00422	0.00422	CcSEcCtD
Metipranolol—Dizziness—Azathioprine—multiple sclerosis	0.0042	0.0042	CcSEcCtD
Metipranolol—Cough—Triamcinolone—multiple sclerosis	0.00415	0.00415	CcSEcCtD
Metipranolol—Hypertension—Triamcinolone—multiple sclerosis	0.0041	0.0041	CcSEcCtD
Metipranolol—Hypertension—Methylprednisolone—multiple sclerosis	0.00409	0.00409	CcSEcCtD
Metipranolol—Myalgia—Triamcinolone—multiple sclerosis	0.00404	0.00404	CcSEcCtD
Metipranolol—Myalgia—Methylprednisolone—multiple sclerosis	0.00404	0.00404	CcSEcCtD
Metipranolol—Anxiety—Methylprednisolone—multiple sclerosis	0.00402	0.00402	CcSEcCtD
Metipranolol—Rash—Azathioprine—multiple sclerosis	0.00401	0.00401	CcSEcCtD
Metipranolol—Dermatitis—Azathioprine—multiple sclerosis	0.004	0.004	CcSEcCtD
Metipranolol—Discomfort—Triamcinolone—multiple sclerosis	0.004	0.004	CcSEcCtD
Metipranolol—Discomfort—Methylprednisolone—multiple sclerosis	0.00399	0.00399	CcSEcCtD
Metipranolol—Headache—Azathioprine—multiple sclerosis	0.00398	0.00398	CcSEcCtD
Metipranolol—Conjunctivitis—Methotrexate—multiple sclerosis	0.0039	0.0039	CcSEcCtD
Metipranolol—Oedema—Triamcinolone—multiple sclerosis	0.00388	0.00388	CcSEcCtD
Metipranolol—Epistaxis—Methotrexate—multiple sclerosis	0.00379	0.00379	CcSEcCtD
Metipranolol—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00379	0.00379	CcSEcCtD
Metipranolol—Nausea—Azathioprine—multiple sclerosis	0.00378	0.00378	CcSEcCtD
Metipranolol—Hypertension—Betamethasone—multiple sclerosis	0.00372	0.00372	CcSEcCtD
Metipranolol—Hypertension—Dexamethasone—multiple sclerosis	0.00372	0.00372	CcSEcCtD
Metipranolol—Asthenia—Mitoxantrone—multiple sclerosis	0.00369	0.00369	CcSEcCtD
Metipranolol—Myalgia—Betamethasone—multiple sclerosis	0.00367	0.00367	CcSEcCtD
Metipranolol—Myalgia—Dexamethasone—multiple sclerosis	0.00367	0.00367	CcSEcCtD
Metipranolol—Anxiety—Dexamethasone—multiple sclerosis	0.00366	0.00366	CcSEcCtD
Metipranolol—Anxiety—Betamethasone—multiple sclerosis	0.00366	0.00366	CcSEcCtD
Metipranolol—Discomfort—Betamethasone—multiple sclerosis	0.00363	0.00363	CcSEcCtD
Metipranolol—Discomfort—Dexamethasone—multiple sclerosis	0.00363	0.00363	CcSEcCtD
Metipranolol—Vision blurred—Prednisone—multiple sclerosis	0.00354	0.00354	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00353	0.00353	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00352	0.00352	CcSEcCtD
Metipranolol—Oedema—Betamethasone—multiple sclerosis	0.00352	0.00352	CcSEcCtD
Metipranolol—Oedema—Dexamethasone—multiple sclerosis	0.00352	0.00352	CcSEcCtD
Metipranolol—Visual impairment—Methotrexate—multiple sclerosis	0.00347	0.00347	CcSEcCtD
Metipranolol—Dyspnoea—Triamcinolone—multiple sclerosis	0.00346	0.00346	CcSEcCtD
Metipranolol—Hypertension—Prednisone—multiple sclerosis	0.00324	0.00324	CcSEcCtD
Metipranolol—Rash—Mitoxantrone—multiple sclerosis	0.00324	0.00324	CcSEcCtD
Metipranolol—Dermatitis—Mitoxantrone—multiple sclerosis	0.00324	0.00324	CcSEcCtD
Metipranolol—Headache—Mitoxantrone—multiple sclerosis	0.00322	0.00322	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.0032	0.0032	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.0032	0.0032	CcSEcCtD
Metipranolol—Myalgia—Prednisone—multiple sclerosis	0.0032	0.0032	CcSEcCtD
Metipranolol—Anxiety—Prednisone—multiple sclerosis	0.00318	0.00318	CcSEcCtD
Metipranolol—Discomfort—Prednisone—multiple sclerosis	0.00316	0.00316	CcSEcCtD
Metipranolol—Hypersensitivity—Prednisolone—multiple sclerosis	0.00311	0.00311	CcSEcCtD
Metipranolol—Oedema—Prednisone—multiple sclerosis	0.00306	0.00306	CcSEcCtD
Metipranolol—Nausea—Mitoxantrone—multiple sclerosis	0.00305	0.00305	CcSEcCtD
Metipranolol—Vision blurred—Methotrexate—multiple sclerosis	0.00296	0.00296	CcSEcCtD
Metipranolol—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00286	0.00286	CcSEcCtD
Metipranolol—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00285	0.00285	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00279	0.00279	CcSEcCtD
Metipranolol—Dizziness—Prednisolone—multiple sclerosis	0.00279	0.00279	CcSEcCtD
Metipranolol—Asthenia—Triamcinolone—multiple sclerosis	0.00278	0.00278	CcSEcCtD
Metipranolol—Asthenia—Methylprednisolone—multiple sclerosis	0.00278	0.00278	CcSEcCtD
Metipranolol—Cough—Methotrexate—multiple sclerosis	0.00274	0.00274	CcSEcCtD
Metipranolol—Myalgia—Methotrexate—multiple sclerosis	0.00267	0.00267	CcSEcCtD
Metipranolol—Rash—Prednisolone—multiple sclerosis	0.00266	0.00266	CcSEcCtD
Metipranolol—Dermatitis—Prednisolone—multiple sclerosis	0.00266	0.00266	CcSEcCtD
Metipranolol—Headache—Prednisolone—multiple sclerosis	0.00264	0.00264	CcSEcCtD
Metipranolol—Discomfort—Methotrexate—multiple sclerosis	0.00264	0.00264	CcSEcCtD
Metipranolol—Dizziness—Triamcinolone—multiple sclerosis	0.00256	0.00256	CcSEcCtD
Metipranolol—Dizziness—Methylprednisolone—multiple sclerosis	0.00256	0.00256	CcSEcCtD
Metipranolol—Asthenia—Betamethasone—multiple sclerosis	0.00252	0.00252	CcSEcCtD
Metipranolol—Asthenia—Dexamethasone—multiple sclerosis	0.00252	0.00252	CcSEcCtD
Metipranolol—Nausea—Prednisolone—multiple sclerosis	0.0025	0.0025	CcSEcCtD
Metipranolol—Rash—Triamcinolone—multiple sclerosis	0.00244	0.00244	CcSEcCtD
Metipranolol—Dermatitis—Triamcinolone—multiple sclerosis	0.00244	0.00244	CcSEcCtD
Metipranolol—Rash—Methylprednisolone—multiple sclerosis	0.00244	0.00244	CcSEcCtD
Metipranolol—Dermatitis—Methylprednisolone—multiple sclerosis	0.00244	0.00244	CcSEcCtD
Metipranolol—Headache—Triamcinolone—multiple sclerosis	0.00243	0.00243	CcSEcCtD
Metipranolol—Headache—Methylprednisolone—multiple sclerosis	0.00242	0.00242	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.00233	0.00233	CcSEcCtD
Metipranolol—Dizziness—Dexamethasone—multiple sclerosis	0.00233	0.00233	CcSEcCtD
Metipranolol—Dizziness—Betamethasone—multiple sclerosis	0.00233	0.00233	CcSEcCtD
Metipranolol—Nausea—Triamcinolone—multiple sclerosis	0.0023	0.0023	CcSEcCtD
Metipranolol—Nausea—Methylprednisolone—multiple sclerosis	0.0023	0.0023	CcSEcCtD
Metipranolol—Dyspnoea—Methotrexate—multiple sclerosis	0.00228	0.00228	CcSEcCtD
Metipranolol—Somnolence—Methotrexate—multiple sclerosis	0.00228	0.00228	CcSEcCtD
Metipranolol—Hypersensitivity—Prednisone—multiple sclerosis	0.00226	0.00226	CcSEcCtD
Metipranolol—Rash—Betamethasone—multiple sclerosis	0.00222	0.00222	CcSEcCtD
Metipranolol—Rash—Dexamethasone—multiple sclerosis	0.00222	0.00222	CcSEcCtD
Metipranolol—Dermatitis—Betamethasone—multiple sclerosis	0.00222	0.00222	CcSEcCtD
Metipranolol—Dermatitis—Dexamethasone—multiple sclerosis	0.00222	0.00222	CcSEcCtD
Metipranolol—Headache—Dexamethasone—multiple sclerosis	0.0022	0.0022	CcSEcCtD
Metipranolol—Headache—Betamethasone—multiple sclerosis	0.0022	0.0022	CcSEcCtD
Metipranolol—Asthenia—Prednisone—multiple sclerosis	0.0022	0.0022	CcSEcCtD
Metipranolol—Nausea—Betamethasone—multiple sclerosis	0.00209	0.00209	CcSEcCtD
Metipranolol—Nausea—Dexamethasone—multiple sclerosis	0.00209	0.00209	CcSEcCtD
Metipranolol—Dizziness—Prednisone—multiple sclerosis	0.00203	0.00203	CcSEcCtD
Metipranolol—Rash—Prednisone—multiple sclerosis	0.00193	0.00193	CcSEcCtD
Metipranolol—Dermatitis—Prednisone—multiple sclerosis	0.00193	0.00193	CcSEcCtD
Metipranolol—Headache—Prednisone—multiple sclerosis	0.00192	0.00192	CcSEcCtD
Metipranolol—Hypersensitivity—Methotrexate—multiple sclerosis	0.00189	0.00189	CcSEcCtD
Metipranolol—Asthenia—Methotrexate—multiple sclerosis	0.00184	0.00184	CcSEcCtD
Metipranolol—Nausea—Prednisone—multiple sclerosis	0.00182	0.00182	CcSEcCtD
Metipranolol—Dizziness—Methotrexate—multiple sclerosis	0.00169	0.00169	CcSEcCtD
Metipranolol—Rash—Methotrexate—multiple sclerosis	0.00161	0.00161	CcSEcCtD
Metipranolol—Dermatitis—Methotrexate—multiple sclerosis	0.00161	0.00161	CcSEcCtD
Metipranolol—Headache—Methotrexate—multiple sclerosis	0.0016	0.0016	CcSEcCtD
Metipranolol—Nausea—Methotrexate—multiple sclerosis	0.00152	0.00152	CcSEcCtD
